Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients.

Authors: Bordin, Veronica, Giani, Luisa, Meregalli, Sofia, Bukovec, Roberta, Vaghi, Massimo Maria, Mandalà, Mario, Paolorossi, Franco, Ardizzoia, Antonio, Tancini, Gabriele, Barni, Sandro, Frigerio, Franco, Fumagalli, Luca, Bordoni, Arrigo, Valsuani, Gianni, Di Felice, Greta, Lissoni, Paolo

Source: Urologia Internationalis; Jan2000, Vol. 64 Issue 1, p3-8, 6p, 3 Charts, 2 Graphs

Subject Terms: ANTINEOPLASTIC agents, IMMUNOTHERAPY, RENAL cell carcinoma, RENAL cancer, INTRAVENOUS therapy